Xealth – a digital prescribing platform that enables physicians and clinicians to prescribe customized digital healthcare content such as exercise programs, educational videos, apps, and services – secured $6 in the latest funding round.
Cerner and LRVHealth co-led the financing round with existing investors Atrium Health, Cleveland Clinic, Froedtert and the Medical College of Wisconsin, MemorialCare Innovation Fund, Providence Ventures, and UPMC as well as Threshold Ventures, McKesson, Novartis, Philips, and ResMed.
According to the company, more than 500,000 programs, services, and videos, plus over 61,000 remote monitoring and devices, have been prescribed through its platform.
The platform help clinicians easily integrate, prescribe, and monitor digital health tools for patients from one location in electronic health records. Care teams will be able to order solutions directly from electronic health records to manage conditions, including behavioral health, chronic diseases, maternity care, and surgery preparation.
“In order for digital health to have lasting impact, it needs to show value and ease for both the care team and patient,” said Mike McSherry, CEO, and Co-Founder of Xealth. “We strongly believe that technology should nurture deeper patient-provider relationships and facilitate information sharing across systems and care settings. It is exciting to work with Cerner to simplify meaningful digital health for its health partners.”
Xealth partners include Amazon, Welldoc, Healthwise, ResMed, and SilverCloud.
“Patients want greater access to their health information and are motivated to help care teams find the most appropriate road to recovery. Xealth and Cerner hope to make it easier and more convenient for patients and clinicians to accelerate health care in a more consumer-centric experience,” said David Bradshaw, Senior Vice President, Consumer and Employer Solutions, Cerner.
The e-Prescribing startup, founded in 2017, has raised approximately $30 million to date, according to Mercom data.
